Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.

to EONNS with background cyanotic congenital heart disease was made. An echocardiogram with colour Doppler interrogation confirmed the diagnosis of Persistent pulmonary hypertension of the newborn. The baby was commenced on compounded oral sildenafil @ 2mg/kg/dose 6 hourly in addition to oxygen therapy. Baby improved and was subsequently discharged home on oral sildenafil, which was discontinued after a normal repeat ECHO Scan done at 2 months of life. Oral compounded sildenafil was found to be a useful alternative in managing PPHN.